Evidence map›Paper›PMID 27357127›Full record

ArticleMicrobiome2016

Variable responses of human microbiomes to dietary supplementation with resistant starch.

A Venkataraman, J R Sieber, A W Schmidt, C Waldron, K R Theis, T M Schmidt

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Microbiome, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06292949 (Effect of Resistant Starch on Symptom Improvement and Intestinal Microbiome in Patients With Functional Constipation), which is not on this map. Cited by 195 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
195citing papers in PubMed, 3 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06292949 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Effect of Resistant Starch on Symptom Improvement and Intestinal Microbiome in Patients With Functional Constipation

TypeinterventionalSponsorHuaping XieRan2023 to 2024Enrolled30ConditionsConstipationArmsResistant starch
3 · Its place in the literature

Who cites it

195 citing papers in PubMed, 3 syntheses or guidelines pooled it, 382 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Consumption of SolnulNutrients · 2023
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

135 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

A VenkataramanDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48105, USA.
J R SieberDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48105, USA.
A W SchmidtDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48105, USA.
C WaldronDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48105, USA.
K R TheisDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48105, USA.
T M SchmidtDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48105, USA. schmidti@umich.edu.
University of Michigan–Ann Arbor · USUniversity of Minnesota, Duluth · US

Funding

PULMONARY CELLULAR AND MOLECULAR BIOLOGY TRAININGT32HL007749 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Pickett Dickson · 1993 to 2026
$19.9M
Howard Hughes Medical Institute 52008119NHLBI NIH HHS T32 HL007749
6 · The paper itself

Abstract

backgroundThe fermentation of dietary fiber to various organic acids is a beneficial function provided by the microbiota in the human large intestine. In particular, butyric acid contributes to host health by facilitating maintenance of epithelial integrity, regulating inflammation, and influencing gene expression in colonocytes. We sought to increase the concentration of butyrate in 20 healthy young adults through dietary supplementation with resistant starch (unmodified potato starch-resistant starch (RS) type 2).

methodsFecal samples were collected from individuals to characterize butyrate concentration via liquid chromatography and composition of the microbiota via surveys of 16S rRNA-encoding gene sequences from the Illumina MiSeq platform. Random Forest and LEfSe analyses were used to associate responses in butyrate production to features of the microbiota.

resultsRS supplementation increased fecal butyrate concentrations in this cohort from 8 to 12 mmol/kg wet feces, but responses varied widely between individuals. Individuals could be categorized into three groups based upon butyrate concentrations before and during RS: enhanced, high, and low (n = 11, 3, and 6, respectively). Fecal butyrate increased by 67 % in the enhanced group (from 9 to 15 mmol/kg), while it remained ≥11 mmol/kg in the high group and ≤8 mmol/kg in the low group. Microbiota analyses revealed that the relative abundance of RS-degrading organisms-Bifidobacterium adolescentis or Ruminococcus bromii-increased from ~2 to 9 % in the enhanced and high groups, but remained at ~1.5 % in the low group. The lack of increase in RS-degrading bacteria in the low group may explain why there was no increase in fecal butyrate in response to RS. The microbiota of individuals in the high group were characterized by an elevated abundance of the butyrogenic microbe Eubacterium rectale (~6 % in high vs. 3 % in enhanced and low groups) throughout the study.

conclusionsWe document the heterogeneous responses in butyrate concentrations upon RS supplementation and identify characteristic of the microbiota that appear to underlie this variation. This study complements and extends other studies that call for personalized approaches to manage beneficial functions provided by gut microbiomes.

Indexed as

BacteriaButyric AcidDietary SupplementsFecesFemaleHigh-Throughput Nucleotide SequencingHumansIntestine, LargeMaleMicrobiotaRNA, Ribosomal, 16SStarchYoung AdultButyric AcidRNA, Ribosomal, 16SStarch

Identifiers

PMID27357127
PMCPMC4928258
OpenAlexW2463548453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.